null (Respiratorius AB) aksje
RESP.ST
Sanntidkr2.1400-0.2000 (-8.55%)
Laster graf...
Respiratorius AB
Market Cap
$16,911,882
Åpning2.2700
Høy2.2700
Lav2.1400
Volum5.29k
P/EN/A
Markedsverdi16.91M
52-ukers høy10.5000
52-ukers lav1.1900
Gj.sn. volum27.81k
UtbytteN/A
BetaN/A
EPS-0.7000
Om null (Respiratorius AB) aksje
Respiratorius AB (publ), a research company, develops pharmaceuticals for the treatment of cancer. The company's products under development include VAL001, that is in Phase III clinical trials for the treatment of diffuse large B-cell lymphoma; and VAL001, a product candidate that is in preclinical phase for the treatment of relapsing diffuse large B-cell lymphoma. Respiratorius AB (publ) was incorporated in 1998 and is based in Lund, Sweden.
Selskapsinformasjon
Børs: Stockholm (STO)
Sektor: Sundhed
Industri: Bioteknologi
Adresse:
Medicon Village
223 81 Lund, Sweden
223 81 Lund, Sweden
Telefon: + 46 7 09 22 41 40
Nettside: https://www.respiratorius.com
Analytikernes aksjeanbefalinger
Denne oversikten gir et raskt innblikk i hvordan analytikere vurderer aksjens potensial basert på deres siste analyser og kursmål.
Laveste kursmål
Gjennomsnittlig kursmål
Median kursmål
Høyeste kursmål